Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full approval, sending the drugmaker's shares soaring and easing concerns around the ...

Q1 2025 Management View CEO John Jacobs highlighted the shift in Novavax's corporate strategy over the past year, ...

Mayank Mamtani, B. Riley Securities, asked about development plan changes post-AACR update and focus beyond CRC. Dr. Goldberg stated, "the shortest distance between presentation and approval is in the ...